TWO SIGMA ADVISERS, LP - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,447,000
-91.1%
30,600
-93.8%
0.00%
-90.5%
Q3 2021$16,203,000
-58.9%
491,600
-21.2%
0.04%
-59.6%
Q2 2021$39,430,000
+33.7%
623,900
-9.2%
0.10%
+28.4%
Q1 2021$29,496,000
-27.2%
687,400
-3.0%
0.08%
-25.0%
Q4 2020$40,532,000
+65.4%
708,600
-12.8%
0.11%
+54.3%
Q3 2020$24,504,000
-18.6%
812,200
-11.8%
0.07%
-20.5%
Q2 2020$30,086,000
+28.0%
921,200
+5.0%
0.09%
-2.2%
Q1 2020$23,500,000
+195.2%
877,200
+237.4%
0.09%
+400.0%
Q4 2019$7,961,000
+367.5%
260,000
+267.8%
0.02%
+350.0%
Q3 2019$1,703,00070,7000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders